These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1968773)

  • 21. Efficacy of methadone versus methadone and guanfacine in the detoxification of heroin-addicted patients.
    San L; Fernandez T; Cami J; Gossop M
    J Subst Abuse Treat; 1994; 11(5):463-9. PubMed ID: 7869468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary results of guanfacine treatment of acute opiate withdrawal.
    Schubert H; Fleischhacker WW; Meise U; Theohar C
    Am J Psychiatry; 1984 Oct; 141(10):1271-3. PubMed ID: 6148895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2003; (3):CD003409. PubMed ID: 12917966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2002; (2):CD003409. PubMed ID: 12076479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003409. PubMed ID: 15495052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2003; (2):CD003409. PubMed ID: 12804464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outpatient opiate detoxification with clonidine.
    Washton AM; Resnick RB
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the inhibitory effects of clonidine and guanfacine on the behavioral and autonomic components of morphine withdrawal in rats.
    Buccafusco JJ; Marshall DC; Turner RM
    Life Sci; 1984 Sep; 35(13):1401-8. PubMed ID: 6148677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of guanfacine and clonidine in essential hypertension: a single-blind crossover study.
    Miach PJ; Louis WJ
    Med J Aust; 1980 Oct; 2(7):395-6. PubMed ID: 7005630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.
    Arnsten AF; Cai JX; Goldman-Rakic PS
    J Neurosci; 1988 Nov; 8(11):4287-98. PubMed ID: 2903226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1996 Dec; 43(1-2):87-91. PubMed ID: 8957147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.
    Agthe AG; Kim GR; Mathias KB; Hendrix CW; Chavez-Valdez R; Jansson L; Lewis TR; Yaster M; Gauda EB
    Pediatrics; 2009 May; 123(5):e849-56. PubMed ID: 19398463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical use of clonidine in outpatient detoxification from opiates.
    Washton AM; Resnick RB
    Prog Clin Biol Res; 1981; 71():277-84. PubMed ID: 7330080
    [No Abstract]   [Full Text] [Related]  

  • 35. Guanabenz acetate: a new, long-acting alpha-two adrenergic agonist for opioid withdrawal.
    Tennant FS; Rawson RA
    NIDA Res Monogr; 1984 Mar; 49():338-43. PubMed ID: 6090917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three methods of opioid detoxification in a primary care setting. A randomized trial.
    O'Connor PG; Carroll KM; Shi JM; Schottenfeld RS; Kosten TR; Rounsaville BJ
    Ann Intern Med; 1997 Oct; 127(7):526-30. PubMed ID: 9313020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.
    Janiri L; Mannelli P; Persico AM; Serretti A; Tempesta E
    Drug Alcohol Depend; 1994 Oct; 36(2):139-45. PubMed ID: 7851281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2002; (1):CD003409. PubMed ID: 11869660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two alpha-noradrenergic agonists (clonidine and guanfacine) on norepinephrine turnover in the cortex of rats during morphine abstinence.
    Zigun JR; Bannon MJ; Roth RH
    Eur J Pharmacol; 1981 Apr; 70(4):565-70. PubMed ID: 6113150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonidine and guanfacine in hypertension.
    Jain AK; Hiremath A; Michael R; Ryan JR; McMahon FG
    Clin Pharmacol Ther; 1985 Mar; 37(3):271-6. PubMed ID: 3882307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.